Sirolimus and Familial Adenomatous Polyposis (FAP)
Status:
Completed
Trial end date:
2018-12-10
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the effect of sirolimus on the progression of
intestinal adenomas in patients with FAP and to assess the safety of this treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)